Capital Performance Advisors LLP bought a new stake in shares of Eli Lilly and Company (NYSE:LLY – Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund bought 373 shares of the company’s stock, valued at approximately $217,000. Other institutional investors and hedge funds also […]